Regulation of type I collagen and interstitial collagenase mRNA expression in human dermal fibroblasts by colchicine and D-penicillamine

Yonsei Medical Journal

Volumn 40, Issue 5, 1999, Pages 490-495

  Chung, Kee Yang ^a   Kang, Dong Seung ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

D penicillamine; Interstitial collagenase; mRNA; Sclerosis; TGF ; Type I collagen

Indexed keywords

COLCHICINE; COLLAGEN TYPE 1; COLLAGENASE; MESSENGER RNA; PENICILLAMINE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PROTEIN EXPRESSION; SKIN FIBROBLAST;

EID: 6544274834     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1999.40.5.490     Document Type: Article

References (27)

1. Elder D, Elenitsas R. Benign pigmented lesions and malignant melanoma. In: Elder D, Elenitsas R, Jaworsky C, Johnson B Jr, editors. Lever's Histopathology of the Skin. 8th ed. Philadelphia: Lippincott-Raven Publishers; 1997. p.626-30.
2. Rowell NR, Goodfield MJD. The connective tissue diseases. In: Champion RH, Burton JL, Ebling FJG, editors. Textbook of Dermatology. Oxford. 5th ed. Oxford: Blackwell Scientific Publications; 1992. p.2225-66.
3. Ditto J, Helin P, Rasmussen O, Lorenzen I. Skin collagen in patients with scleroderma: Biosynthesis and maturation in vitro and the effect of D-penicillamine. Ann Clin Res 1970;2:228-34.
4. Nimni ME. Penicillamine and collagen metabolism. Scand J Rheumatol Suppl 1979;28:71-8.
5. Schumacher K. Basis of immunosuppressive effect of D-penicillamine. Internist 1975;16:450-65.
6. Epstein O, De Villiers D, Jain S, Potter BJ, Thomas HC, Sherlock S. Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis. N Engl J Med 1979;300:274-8.
7. Dehm P, Prockop J. Time lag in the secretion of collagen by matrix-free tendon cells and inhibition of the secretory process by colchicine and vinblastine. Biochim Biophys Acta 1972;264:75.
8. Diegelmann RF, Peterkofsky B. Inhibition of collagen from bone and cultured fibroblasts by microtubular disruptive drugs. Proc Natl Acad Sci USA 1972;69:892-6.
9. Ehrlich HP, Bornstein P. Microtubules in transcellular movement of procollagen. Nature New Biol 1972;238:257-60.
10. Harris ED Jr, Krane SM. Effects of colchicine on collagenase in cultures of rheumatoid synovium. Arthritis Rheum 1971;14:669-84.
11. Alarcon-Segovia D, Ramos-Niembro F, Ibanez de Kasep G, Alcocer J, Tamayo RP. Long-term evaluation of colchicine in the treatment of scleroderma. J Rheumatol 1979;6:705-12.
12. Jimenez SA, Sigal H. A fifteen-year prospective study of treatment of rapidly progressive sclerosis (PSS) with D-penicillamine (D-PEN). Arthritis Rheum 1989;32:S34.
13. Steen VD, Blair S, Medsger Jr TA. The toxicity of D-penicillamine in systemic sclerosis. Ann Intern Med 1986; 104:699-705.
14. Uitto J, Jimenez S. Fibrotic skin disease. Arch Dermatol 1990;126:661-4.
15. Varga J, Jimenez SA. Modulation of collagen gene expression: Its relation to fibrosis in systemic sclerosis and other disorders. Ann Intern Med 1995;122:60-2.
16. Chung KY, Agarwal A, Uitto J, Mauviel A. An AP-1 binding sequence is essential for regulation of the human α2 (I) collagen (COL1A2) promoter activity by transforming growth factor-β J Biol Chem 1996;271:3272-8.
17. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987;6:1899-904.
18. Uria JA, Jimenez MG, Balbin M, Freije JMP, Lopez-Otin C. Differential effects of transforming growth factor-β on the expression of collagenase-1 and collagenase-3 in human fibroblasts. J Biol Chem 1998;273:9769-77.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
20. Kikuchi K, Hartl CW, Smith EA, LeRoy EC, Trojanowska M. Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity to TGF beta 1 stimulation. Biochem Biophys Res Commun 1992;187:45-50.
21. Broekelmann TJ, Limper AH, Colby TV, McDonald JA. Transforming growth factor beta 1 is present at site of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad USA 1991;88:6642-6.
22. Kouba DJ, Chung KY, Nishiyama T, Vindevoghel L, Kon A, Klement JF, et al. Nuclear Factor-B mediates TNF-inhibitory effect on α2 (I) collagen (COL1A2) gene transcription in human dermal fibroblasts. J Immunol 1999; 162:4226-34.
23. Solis-Herruzo JA, Brenner DA, Chojkier M. Tumor necrosis factor α inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts. J Biol Chem 1988;263:5841-5.
24. Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M. Prolonged activation of jun and collagenase genes by tumor necrosis factor-α. Nature 1989;337:661-3.
25. Lefebvre V, Peeters-Joris C, Vaes G. Modulation by interleukin 1 and tumor necrosis factor α of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim Biophysica Acta 1990;1052:366-78.
26. Mauviel A, Heino J, Kahari VM, Hartmann DJ, Loyau G, Pujol JP, et al. Comparative effects of interleukin-1 and tumor necrosis factor-α on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol 1991;96:243-9.
27. Takeda K, Hatamochi A, Arakawa M, Ukei H. Effects of tumor necrosis factor-α on connective tissue metabolism in normal and scleroderma fibroblast cultures. Arch Dermatol Res 1993;284:440-4.